LeMaitre Vascular
LMAT
307 hedge funds and large institutions have $1.95B invested in LeMaitre Vascular in 2024 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 123 increasing their positions, 96 reducing their positions, and 25 closing their positions.
72% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 25
28% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 96
24% more call options, than puts
Call options by funds: $332K | Put options by funds: $267K
5% more funds holding
Funds holding: 291 → 307 (+16)
0.82% more ownership
Funds ownership: 93.45% → 94.27% (+0.82%)
0% more capital invested
Capital invested by funds: $1.95B → $1.95B (+$3.2M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| 1 |
BlackRock
New York
|
+$22.8M |
| 2 |
Rockefeller Capital Management
New York
|
+$8.13M |
| 3 |
Goldman Sachs
New York
|
+$7.84M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$5.68M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.65M |
Top Sellers
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$27.5M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$9.13M |
| 3 |
FMI
F/M Investments
Washington,
District of Columbia
|
-$8.17M |
| 4 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$6.58M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.81M |
LMAT Hedge Fund Activity: Q4 2024 in Review
307 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2024, worth a combined $1.95B — up 0.16% from $1.95B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new LMAT positions and 25 closed out — a net gain of 18 holders — while 123 added to existing stakes and 96 trimmed.
The largest buyer was BlackRock, adding an estimated $22.8M. The largest seller was Conestoga Capital Advisors, cutting an estimated $27.5M.
- 307 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2024, up from 291 in Q3 2024.
- Funds reported $1.95B of LeMaitre Vascular stock for Q4 2024, up 0.16% quarter-over-quarter.
- 43 funds opened new LeMaitre Vascular positions in Q4 2024 and 25 closed out, a net change of +18 holders.
- The largest LeMaitre Vascular buyer in Q4 2024 was BlackRock, an estimated $22.8M added.
- The largest LeMaitre Vascular seller in Q4 2024 was Conestoga Capital Advisors, an estimated $27.5M sold.
Based on aggregated 13F filings for Q4 2024.